CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

• Main Authors: Sychev DA (Author), Baturina OA (Author), Mirzaev KB (Author), Rytkin E (Author), Ivashchenko DV (Author), Andreev DA (Author), Ryzhikova KA (Author), Grishina EA (Author), Bochkov PO (Author), Shevchenko RV (Author)
• Format: Book
• Published: Dove Medical Press, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

DA Sychev,1 OA Baturina,2 KB Mirzaev,1 E Rytkin,1 DV Ivashchenko,1 DA Andreev,2 KA Ryzhikova,1 EA Grishina,1 PO Bochkov,1 RV Shevchenko1 1Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Moscow, Russian Federation; 2Sechenov University, Mosc...